GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over ...

The Department of Health and Human Services is endorsing self-collected vaginal samples for cervical cancer screening and requiring most private insurance plans to cover testing without cost sharing.

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Aging is inevitable as death and taxes but the rate we change varies a lot between individuals," Dr. Kuchel said.

New medications are in the pipeline that could help people win their battles against addictive substances, including opioids ...

Congratulations to the green sea turtle, which is off the endangered species list as of 2025 thanks to a population rebound.

The "Personal Care Active Ingredients Market, 2024-2031" report has been added to ResearchAndMarkets.com's offering. The revenue estimate for the base year 2024 is $3.99 billion, with a CAGR of 6.2% ...

For more than a century, Alzheimer’s disease has been treated as a one‑way slide, something that could perhaps be slowed but ...